A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon
about
Activation of RelA homodimers by tumour necrosis factor alpha: a possible transcriptional activator in human vascular endothelial cellsA novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerizationDimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3)Polymerase chain reaction selects a novel disintegrin proteinase from CD40-activated germinal center dendritic cellsA novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase geneThe p65 subunit is responsible for the strong transcription activating potential of NF-kappa BEvolutionary variation of the CCAAT-binding transcription factor NF-YHuman biliary glycoprotein gene: characterization of a family of novel alternatively spliced RNAs and their expressed proteinsPurification, reconstitution, and I kappa B association of the c-Rel-p65 (RelA) complex, a strong activator of transcriptionNF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like moleculeA novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B siteRegulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteinsRegulation of human immunodeficiency virus enhancer function by PRDII-BF1 and c-rel gene productsPhysical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cellsTransdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplicationDNA tetraplex formation in the control region of c-mycPhosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa BThe c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response elementCharacterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loopNF-kappa B subunit-specific regulation of the interleukin-8 promoterTumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activationHuman genomic sequences that inhibit splicing.The p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor.Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein RELThe majority of human genes have regions repeated in other human genes.The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.Transposable elements have contributed to thousands of human proteins.Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation.Proteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p105 are obligatory steps in the activation of NF-kappa B.Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.c-Rel plays a key role in deficient activation of B cells from a non-X-linked hyper-IgM patient.Moloney murine leukemia virus activates NF-kappa BInhibition of transcription factors belonging to the rel/NF-kappa B family by a transdominant negative mutantThe c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alphaIdentification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomasNF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation.Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stabilityIdentification of the rel family members required for virus induction of the human beta interferon gene.The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers.
P2860
Q24301448-406C255C-601F-4111-87B8-0D71A5AEB021Q24320246-292DEC66-36A6-4CEA-8C22-4959DFE8C1C2Q24321796-E8835191-8D0A-4237-A29D-34CDDF41124CQ24336346-211A8A38-1915-4232-8483-125C3660E7DDQ24555708-009D9E33-B14D-47DC-A60F-27DA5AE4C250Q24564667-8DCA1CD8-F4C5-40E0-BC9A-23D3BC353377Q24608611-E4240435-4B52-4505-8164-482912561AC7Q24610681-9BB2DCEA-5E6A-4294-BDEB-DB6A5FA1C675Q24613327-1A7999C3-9B77-4662-9886-C3E4230CC159Q24629772-680D3EDA-6639-4724-BD08-8F5DF6F6C655Q24630534-25DCD2B3-08AE-4C4C-9578-7FB77BCB2762Q24652745-36204246-7233-403F-845F-9453A1B04400Q24655654-D97B84EC-8FA0-4D21-8B5A-5DDB0FFD364AQ24675272-FFEE7DAA-5101-4EBB-A41C-63121DA1BD21Q24681560-613F3400-623E-4736-A628-EAE3463EEDBAQ28262361-C3DC2FB7-753B-4B53-A44D-FD9A425AD2FAQ28615823-B54F085D-CE3B-43CA-B191-B575C75D7E13Q28645819-3B82F1B1-2D73-42B7-992D-BFBD6D2636E2Q28645865-BE3D663D-D588-4DF7-B1B8-F6DC0D7B1AB4Q28646361-0089A758-BD0F-403D-8B42-159249F4E535Q28776205-338F2FEE-CAFC-4AC2-8B70-9DFB0CF2ECDDQ30910840-C2ACE495-B604-4145-AAE7-D5E80EDE0D23Q31076639-A48C767E-9803-4247-9D49-A6AE1A6B102EQ33706844-EAEF5FB2-B2AC-4C57-9C72-13A79BD0EC82Q33935476-CD36A256-21FD-4BFF-BA0B-54021FAF7C6BQ34061332-49E46726-F586-4EB9-922E-30A18CB36C2FQ34478671-0750770B-227A-4FA4-8BD9-3772C82F78C7Q34811265-3FB3C7FB-AB94-4053-8697-04FF98975141Q35019615-513DCF07-7610-4A1F-B0D2-C36A06F374BDQ35643358-B3B8D252-14D8-49A5-AC4A-2AC6E9100106Q35848908-68071EBB-F391-4DA0-A85B-351D0F659C70Q35862437-CB3B4A3D-2742-431A-8423-1953A2A6E0E7Q35926996-C56960E2-B844-42A1-923D-0DE506E5FAA7Q36086609-BC385E8C-318A-4958-B57A-5F6BCB457686Q36180990-423447DB-D3E6-4805-B92D-D25E65E2E8A6Q36346660-D0A73E48-C4E0-48F8-97A2-66E2774876FAQ36362688-261646D4-9732-42E6-8209-FA2CD8B04145Q36557754-AEF492AA-7686-4B6E-9FD4-EE46763A121AQ36566451-D9ED5422-7B03-4880-B09E-5ED59D92317FQ36566875-C1D5406B-7475-4284-B605-7E031B51A877
P2860
A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon
description
1989 nî lūn-bûn
@nan
1989 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon
@ast
A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon
@en
A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon
@nl
type
label
A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon
@ast
A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon
@en
A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon
@nl
prefLabel
A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon
@ast
A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon
@en
A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon
@nl
P2093
P1433
P1476
A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon
@en
P2093
P304
P407
P577
1989-07-01T00:00:00Z